# To Evaluate the Change in Glucose Parameters in Adult Patients With Type 1 or Type 2 Diabetes From Europe Using the iCan o3 CGM System for 60 Days Period

> **NCT06904846** · NA · ENROLLING_BY_INVITATION · sponsor: **Sinocare** · enrollment: 70 (estimated)

## Conditions studied

- Diabetes Mellitus
- Continuous Glucose Monitoring System

## Interventions

- **DEVICE:** iCan o3 CGM Continuous Glucose Monitoring System

## Key facts

- **NCT ID:** NCT06904846
- **Lead sponsor:** Sinocare
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2025-04-23
- **Primary completion:** 2026-04-30
- **Final completion:** 2026-06-30
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2026-01-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06904846

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06904846, "To Evaluate the Change in Glucose Parameters in Adult Patients With Type 1 or Type 2 Diabetes From Europe Using the iCan o3 CGM System for 60 Days Period". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06904846. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*